MIRA INFORM REPORT

 

 

Report Date :

18.04.2014

 

IDENTIFICATION DETAILS

 

Name :

INTERNATIONAL ONCOLOGY SERVICES PRIVATE LIMITED

 

 

Registered Office :

206, Chaudhary Complex, 9, Veer Sawarkar Block, Shakarpur, Delhi-110092

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

04.10.2005

 

 

Com. Reg. No.:

55-141431

 

 

Capital Investment / Paid-up Capital :

Rs.104.034 Millions

 

 

CIN No.:

[Company Identification No.]

U85110DL2005PTC141431

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Medical, Non-Medical and Diagnostics Equipments.

 

 

No. of Employees :

90 [Approximately] 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (33)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 1049700

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

Rating reflects moderate financial risk profile due to loss recorded by the company in the year 2013.

 

However, trade relations are fair. Business is active. Payment terms are slow.

 

The company can be considered for business dealing with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs  has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Girish Uniyal

Designation :

Accountant

Contact No.:

91-9910930837

Date :

16.04.2014

 

 

LOCATIONS

 

Registered Office :

206, Chaudhary Complex, 9, Veer Sawarkar Block, Shakarpur, Delhi-110092, India

Tel. No.:

Not Available

Mobile No.:

91-9910930837 [Mr. Girish Uniyal]

Fax No.:

Not Available

E-Mail :

girish.uniyal@internationaloncology.com

info@internationaloncology.com

siddharth.singh@internationaloncology.com

Website :

www.internationaloncology.com

Location :

Owned

 

 

Corporate Office :

2215, The Corenthum (Tower A), A-41, Sector 62, Noida-201301, Uttar Pradesh, India

Tel. No.:

91-120-4220760/1

Fax No.:

91-120-4220762

 

 

Pharmacy :

1st Floor, Room No. F-102, Oncology Department, Fortis Hospital, B-1, Vasant Kunj, Delhi-110070, India

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Pradeep Kumar Jaisingh

Designation :

Managing Director

Address :

803, Tower 3, Parsavnath Prestige, Sector 93A, Noida-201301, Uttar Pradesh, India

Date of Birth/Age :

05.08.1964

Date of Appointment :

24.09.2007

Din No.:

01676317

Other Directorship:

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U85110DL2005PTC141431

INTERNATIONAL ONCOLOGY SERVICES PRIVATE LIMITED

Managing director

10-11-2008

24-09-2007

Active

NO

2

U74900DL2011PTC220574

INTERNATIONAL ONCOPLANS SERVICES PRIVATE LIMITED

Director

08-06-2011

08-06-2011

Active

NO

3

U85100DL2013PTC261321

HEALTHSTART INDIA PRIVATE LIMITED

Director

28-11-2013

28-11-2013

Active

NO

 

 

Name :

Mr. Madhur Kumar Garg

Designation :

Director

Address :

1134, Dobbs Ferry Road, White Plains, NY, White

Date of Birth/Age :

27.07.1968

Date of Appointment :

04.10.2005

Din No.:

01550937

 

 

Name :

Ashvini Sengar

Designation :

Whole Time Director

Address :

A-002/E8, Sector 61, Krishna Apra Residency, Noida-201307, Uttar Pradesh, India

Date of Birth/Age :

24.05.1968

Date of Appointment :

04.10.2005

Din No.:

01698935

Other Directorship:

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U85110DL2005PTC141431

INTERNATIONAL ONCOLOGY SERVICES PRIVATE LIMITED

Whole-time director

01-08-2008

04-10-2005

Active

NO

2

U85110DL2008PTC177963

INNOVATIVE PROSTHETICS AND ORTHOTICS PRIVATE LIMITED

Director

12-05-2008

12-05-2008

Active

NO

3

U22212MH2008PTC186873

RANGOLI MEDIA PRIVATE LIMITED

Director

18-09-2008

18-09-2008

Active

NO

 

 

Name :

Mr. Girish Gupta

Designation :

Nominee Director

Address :

B-119, Hari Marg, Malviya Nagar, Jaipur-302017, Rajasthan, India

Date of Birth/Age :

18.02.1957

Date of Appointment :

04.07.2012

Din No.:

00894066

Other Directorship:

S. No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U51505RJ1985SGC003193

RAJASTHAN ELECTRONICS LTD.

Director

12-06-1990

12-06-1990

12-07-2010

Strike off

NO

2

U65999RJ2002PTC017380

RAJASTHAN ASSET MANAGEMENT COMPANY PRIVATE LIMITED

Director

21-12-2006

11-10-2004

-

Active

NO

3

U65999RJ2002PTC017379

RAJASTHAN TRUSTEE COMPANY PRIVATE LIMITED

Nominee director

11-10-2004

11-10-2004

-

Active

NO

4

U92111DL2003PTC123453

ESCOTOONZ ENTERTAINMENT PRIVATE LIMITED

Nominee director

11-02-2005

11-02-2005

12-10-2007

Active

NO

5

U31909RJ1995PTC010472

NATURAL TECHNOLOGIES PRIVATE LIMITED

Nominee director

09-03-2005

09-03-2005

20-03-2008

Amalgamated

NO

6

U72200RJ2001PTC017138

CYBER FUTURISTICS INDIA PRIVATE LIMITED

Director

21-10-2005

21-10-2005

-

Active

NO

7

U93010DL2002PTC117667

LIQVID ELEARNING SERVICES PRIVATE LIMITED

Nominee director

20-04-2006

20-04-2006

22-10-2010

Active

NO

8

U01119DL1996PLC080659

HOME STORES (INDIA) LIMITED

Nominee director

30-06-2006

30-06-2006

14-06-2007

Active

NO

9

U72900GJ2006PTC047970

AAA IT SOLUTIONS PRIVATE LIMITED

Nominee director

01-06-2009

01-06-2009

-

Active

NO

10

U45201RJ2003PTC018013

GEETASTAR HOTELS AND RESORTS PRIVATE LIMITED

Nominee director

25-08-2009

25-08-2009

-

Active

NO

11

U63040DL2007PTC164791

E FACTOR ADVENTURE TOURISM PRIVATE LIMITED

Nominee director

10-09-2009

10-09-2009

-

Active

NO

12

U52392MH2000PTC126159

NEXTENDERS (INDIA) PRIVATE LIMITED

Nominee director

29-09-2011

18-05-2011

-

Active

NO

13

U80302RJ2008PTC026456

SHREE EDUSERVE PRIVATE LIMITED

Nominee director

27-05-2011

27-05-2011

21-12-2012

Active

NO

14

U63000HR2010PLC040312

LEEWAY LOGISTICS LIMITED

Nominee director

23-06-2011

23-06-2011

-

Active

NO

15

U85110TN2003PTC051101

FRONTIER LIFELINE PRIVATE LIMITED

Nominee director

17-04-2012

17-04-2012

-

Active

NO

16

U85110DL2005PTC141431

INTERNATIONAL ONCOLOGY SERVICES PRIVATE LIMITED

Nominee director

04-07-2012

04-07-2012

-

Active

NO

17

U72200KA2008PTC045218

AUJAS NETWORKS PRIVATE LIMITED

Additional director

22-11-2013

22-11-2013

-

Active

NO

 

 

Name :

Mr. Hari K Vallurupalli

Designation :

Nominee Director

Address :

4395, Shamrock Drive Frisco, TX-75034, US

Date of Birth/Age :

09.08.1966

Date of Appointment :

04.07.2012

Din No.:

01421390

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U72200AP1995PTC022599

B-IQ TECHNOLOGIES Private LIMITED

Director

28-12-2000

28-12-2000

-

Active

NO

2

U45200AP2007PTC052250

TRIVIKRAM CONSTRUCTIONS AND DEVELOPERS PRIVATE LIMITED

Director

23-04-2007

23-04-2007

-

Active

NO

3

U74999AP2007NPL085655

CEO CLUBS INDIA

Director

31-07-2012

05-10-2007

-

Active

NO

4

U15429KA1999PLC026121

NSL SUGARS LIMITED

Whole-time director

03-12-2010

03-12-2010

29-09-2012

Active

NO

5

U70102AP2011PTC072414

HARIPRIYA CONVENTION CENTER PRIVATE LIMITED

Director

28-01-2011

28-01-2011

-

Active

NO

6

U40102KA1983PLC058128

NSL SUGARS (TUNGABHADRA) LIMITED

Managing director

13-06-2011

13-06-2011

29-09-2012

Active

NO

7

U15421MH2000PLC130397

JAY MAHESH SUGAR INDUSTRIES LIMITED

Director

30-09-2011

25-06-2011

-

Amalgamated

NO

8

U74900AP2012PTC081143

VINCIEN ADVISORS PRIVATE LIMITED

Director

28-05-2012

28-05-2012

-

Active

NO

9

U85110DL2005PTC141431

INTERNATIONAL ONCOLOGY SERVICES PRIVATE LIMITED

Nominee director

04-07-2012

04-07-2012

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Siddharth Singh

Designation :

Secretary

Address :

A-40, Radhey Shyam Park, (Ext), Delhi-110051, India

Date of Appointment :

11.05.2012

Pan No.:

CGDPS3445N

 

 

Name :

Mr. Girish Uniyal

Designation :

Accountant

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

 

 

No. of Shares

Malti Sanger

 

5000

Swati Aggarwal

 

13333

Ashvini Sengar

 

2080414

Madhur Kumar Garg

 

2027351

Pradeep Kumar Jaisingh

 

2840225

Manish Dhawan

 

240291

Trivikram Constructions and Developers Private Limited, India

 

1000000

Pankaj Rajvanshi

 

44000

Anurag Walia

 

46650

Anup Sethi

 

30811

Ajay Rastogi

 

270416

Rahul Jain

 

54083

Rajasthan Trustee Company Private Limited, India  A/c SME Tech Fund, RVCF Trust II, India

 

1642598

Sunil Baijal

 

108167

 

 

AS ON 30.09.2013

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Venture capital

 

15.79

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

6.30

Bodies corporate

 

9.61

Directors or relatives of directors

 

66.96

Other top fifty shareholders

 

1.34

TOTAL

 

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Medical, Non-Medical and Diagnostics Equipments.

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

Others

 

 

No. of Employees :

90 [Approximately] 

 

 

Bankers :

  • Indus-Ind Bank Limited, Dr. Gopal Das Bhawan, 28 Barakhamba Road, New Delhi - 110001, India

 

  • Axis Bank Limited, 148, Barakhamba Road, Statesman House, 2nd Floor, New Delhi - 110001, India

 

 

Facilities :

Secured Loan

As on 31.03.2013

[Rs. in Millions]

As on 31.03.2012

[Rs. in Millions]

Long Term Borrowings

 

 

Rupee term loans from banks

130.812

77.197

Other loans and advances

0.424

0.000

Deferred payment liabilities

0.000

95.696

 

 

 

Short Term Borrowings

 

 

Term loans from banks

44.662

41.930

Working capital loans from banks

48.590

57.950

Other loans and advances

0.130

0.000

TOTAL

224.618

272.773

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

P.R. Mehra and Company

Chartered Accountants

Address :

56, Daryaganj, Delhi-110002, India

PAN No:

AAEFP1838M

 

 

Other Related Parties :

  • Outcancer Foundation
  • International Oncoplans Services Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

15000000

Equity Shares

Rs.10/- each

Rs.150.000 Millions

22500000

Preferences Shares

Rs.10/- each

Rs.225.000 Millions

 

TOTAL

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10403369

Equity Shares

Rs.10/- each

Rs.104.034 Millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

104.034

83.281

83.114

(b) Reserves & Surplus

158.409

14.107

30.414

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

56.000

0.000

Total Shareholders’ Funds (1) + (2)

262.443

153.388

113.528

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

131.236

172.893

154.893

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

25.769

44.357

77.693

(d) long-term provisions

3.595

2.494

0.453

Total Non-current Liabilities (3)

160.600

219.744

233.039

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

93.382

99.880

79.302

(b) Trade payables

49.111

49.606

48.895

(c) Other current liabilities

71.018

64.668

65.770

(d) Short-term provisions

0.178

0.046

0.000

Total Current Liabilities (4)

213.689

214.200

193.967

 

 

 

 

TOTAL

636.732

587.332

540.534

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

463.444

434.464

435.473

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.077

0.021

0.070

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

31.770

14.448

0.000

(d)  Long-term Loan and Advances

0.187

0.175

0.203

(e) Other Non-current assets

0.000

2.500

0.000

Total Non-Current Assets

495.478

451.608

435.746

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

3.379

3.047

8.697

(c) Trade receivables

121.236

106.840

83.216

(d) Cash and cash equivalents

2.773

2.584

2.304

(e) Short-term loans and advances

0.402

2.839

0.000

(f) Other current assets

13.464

20.414

10.571

Total Current Assets

141.254

135.724

104.788

 

 

 

 

TOTAL

636.732

587.332

540.534

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

 

 

SALES

 

 

 

 

Income

248.603

234.285

156.802

 

Other Income

5.372

16.164

2.798

 

TOTAL (A)

253.975

250.449

159.600

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Stores and Consumables

93.926

93.339

57.229

 

Administrative Expenses

72.866

79.801

50.765

 

Personnel Expenses

64.504

45.310

22.101

 

TOTAL (B)

231.296

218.450

130.095

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

22.679

31.999

29.505

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

31.265

32.844

10.746

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

(8.586)

(0.845)

18.759

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

33.650

31.738

20.388

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

(42.236)

(32.583)

(1.629)

 

 

 

 

 

Less

TAX                                                          (H)

(17.322)

(14.448)

(0.039)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-H)      (I)

(24.914)

(18.135)

(1.590)

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(2.39) 

--

--

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

(9.81)

(7.24)

(1.00)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(16.99)

(13.91)

(1.04)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(6.98)

(5.69)

(0.30)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.16)

(0.21)

(0.01)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.85

1.77

2.06

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.66

0.63

0.54

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

83.114

83.281

104.034

Reserves & Surplus

30.414

14.107

158.409

Net worth

113.528

97.388

262.443

 

 

 

 

long-term borrowings

154.893

172.893

131.236

Short term borrowings

79.302

99.880

93.382

Total borrowings

234.195

272.773

224.618

Debt/Equity ratio

2.063

2.801

0.856

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

156.802

234.285

248.603

 

 

49.415

6.111

 

 


 


NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

156.802

234.285

248.603

Profit

(1.590)

(18.135)

(24.914)

 

(1.01%)

(7.74%)

(10.02%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES:

 

S. NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10274796

26/12/2013 *

126,800,000.00

INDUSIND BANK LIMITED

DR. GOPAL DAS BHAWAN, 28 BARAKHAMBA ROAD, NEW DELHI - 110001, INDIA

B94086683

2

10131652

21/01/2013 *

282,500,000.00

AXIS BANK LIMITED

148, BARAKHAMBA ROAD, STATESMAN HOUSE, 2ND FLOOR, 
NEW DELHI - 110001, INDIA

B68255173

 

* Date of charge modification

 

 

FINANCIAL HIGHLIGHTS AND OPERATIONS:

 

The Company during the financial year had a stable performance going by the increase in revenue as compared to the last year. The Company witnessed a 6% y-o-y growth in its medical receipts revenues which was less than expected growth mainly due to shortfall in internal referrals from partner hospital at their Fortis Noida Center as some of their key medical specialties did not register projected revenue growth. The revenue growth at Fortis Noida Center also got adversely affected due to some government policies measures such as mandatory discount of 10% on oncology drugs administered to the ECHS patients which constitutes a large part of their institutional patient revenues. The lower revenue achievement at Fortis Noida Center was also due to delay in approval of the inclusion of the radiation therapy in the ECHS empanelment.

 

The operational performance ramp up at their third center at Jodhpur which became operational from September 2012 was hampered mainly due to non-commissioning of surgical program due to delays in completion of modular operational theater and installation of CT machine by the partner hospital. It is to be noted that a majority of radiation revenue is driven from internal surgical referrals.

 

On a positive note, the center at Dr. L.H. Hiranandani Hospital, Mumbai which had its second full year of operations has shown a very encouraging growth in revenue generation over the last year and has been performing consistently. The center registered a 38% growth in its revenues as compared to last financial year.

 

The Company is committed to consistent growth mode and enlarging the revenue base in the coming years and has taken challenging revenue and profitability targets for the current financial year. The Company has taken many steps in this regard e.g. increasing the number of outreach centers and further expansion in patient referral arrangements. The Company continues to strengthen its position as one of the leading provider of cancer care and treatment in India backed up by the use of start-of-the-art technology and best in class treatment protocols followed by it.

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.38

UK Pound

1

Rs.101.63

Euro

1

Rs.83.57

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

SUM

 

 

Report Prepared by :

TPT

 

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

4

--RESERVES

1~10

4

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

33

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.